microRNA Regulation in Estrogen Receptor-Positive Breast Cancer and Endocrine Therapy

As de novo and acquired resistance to standard first line endocrine therapies is a growing clinical challenge for estrogen receptor-positive (ER(+)) breast cancer patients, understanding the mechanisms of resistance is critical to develop novel therapeutic strategies to prevent therapeutic resistanc...

Descripción completa

Detalles Bibliográficos
Autores principales: Howard, Erin W., Yang, Xiaohe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6134714/
https://www.ncbi.nlm.nih.gov/pubmed/30214383
http://dx.doi.org/10.1186/s12575-018-0082-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6134714/
https://www.ncbi.nlm.nih.gov/pubmed/30214383
http://dx.doi.org/10.1186/s12575-018-0082-9

Ejemplares similares